138 related articles for article (PubMed ID: 38244700)
21. Multigroup prediction in lung cancer patients and comparative controls using signature of volatile organic compounds in breath samples.
Rai SN; Das S; Pan J; Mishra DC; Fu XA
PLoS One; 2022; 17(11):e0277431. PubMed ID: 36449484
[TBL] [Abstract][Full Text] [Related]
22. Differentiating interstitial lung diseases from other respiratory diseases using electronic nose technology.
van der Sar IG; Wijsenbeek MS; Braunstahl GJ; Loekabino JO; Dingemans AC; In 't Veen JCCM; Moor CC
Respir Res; 2023 Nov; 24(1):271. PubMed ID: 37932795
[TBL] [Abstract][Full Text] [Related]
23. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
24. Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
Barnes H; Holland AE; Westall GP; Goh NS; Glaspole IN
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD010908. PubMed ID: 29297205
[TBL] [Abstract][Full Text] [Related]
25. Exhaled volatile organic compounds detect pulmonary exacerbations early in children with cystic fibrosis: results of a 1 year observational pilot study.
van Horck M; Smolinska A; Wesseling G; de Winter-de Groot K; de Vreede I; Winkens B; Jöbsis Q; Dallinga J; Dompeling E; van Schooten FJ
J Breath Res; 2021 Feb; 15(2):026012. PubMed ID: 33630756
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis by Volatile Organic Compounds in Exhaled Breath from Lung Cancer Patients Using Support Vector Machine Algorithm.
Sakumura Y; Koyama Y; Tokutake H; Hida T; Sato K; Itoh T; Akamatsu T; Shin W
Sensors (Basel); 2017 Feb; 17(2):. PubMed ID: 28165388
[TBL] [Abstract][Full Text] [Related]
27. Breath biomarkers in idiopathic pulmonary fibrosis: a systematic review.
Hayton C; Terrington D; Wilson AM; Chaudhuri N; Leonard C; Fowler SJ
Respir Res; 2019 Jan; 20(1):7. PubMed ID: 30634961
[TBL] [Abstract][Full Text] [Related]
28. Differentiation of Idiopathic Pulmonary Fibrosis from Connective Tissue Disease-Related Interstitial Lung Disease Using Quantitative Imaging.
Chung JH; Adegunsoye A; Cannon B; Vij R; Oldham JM; King C; Montner SM; Thirkateh P; Barnett S; Karwoski R; Bartholmai BJ; Strek M; Nathan SD
J Clin Med; 2021 Jun; 10(12):. PubMed ID: 34204184
[TBL] [Abstract][Full Text] [Related]
29. Comparison of characteristics of connective tissue disease-associated interstitial lung diseases, undifferentiated connective tissue disease-associated interstitial lung diseases, and idiopathic pulmonary fibrosis in Chinese Han population: a retrospective study.
Pan L; Liu Y; Sun R; Fan M; Shi G
Clin Dev Immunol; 2013; 2013():121578. PubMed ID: 24171031
[TBL] [Abstract][Full Text] [Related]
30. Molecular breath analysis supports altered amino acid metabolism in idiopathic pulmonary fibrosis.
Gaugg MT; Engler A; Bregy L; Nussbaumer-Ochsner Y; Eiffert L; Bruderer T; Zenobi R; Sinues P; Kohler M
Respirology; 2019 May; 24(5):437-444. PubMed ID: 30681243
[TBL] [Abstract][Full Text] [Related]
31. Serum IL-36 cytokines levels in idiopathic pulmonary fibrosis and connective tissue disease-associated interstitial lung diseases.
Zhang Q; Guo L; Song X; Lv C; Tang P; Li Y; Ding Q; Li M
Clin Chim Acta; 2022 May; 530():8-12. PubMed ID: 35219714
[TBL] [Abstract][Full Text] [Related]
32. Exhaled breath analysis in interstitial lung disease.
van der Sar IG; Wijsenbeek MS; Moor CC
Curr Opin Pulm Med; 2023 Sep; 29(5):443-450. PubMed ID: 37405699
[TBL] [Abstract][Full Text] [Related]
33. Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis.
Goh NS; Hoyles RK; Denton CP; Hansell DM; Renzoni EA; Maher TM; Nicholson AG; Wells AU
Arthritis Rheumatol; 2017 Aug; 69(8):1670-1678. PubMed ID: 28426895
[TBL] [Abstract][Full Text] [Related]
34. Virus-induced Volatile Organic Compounds Are Detectable in Exhaled Breath during Pulmonary Infection.
Kamal F; Kumar S; Edwards MR; Veselkov K; Belluomo I; Kebadze T; Romano A; Trujillo-Torralbo MB; Shahridan Faiez T; Walton R; Ritchie AI; Wiseman DJ; Laponogov I; Donaldson G; Wedzicha JA; Johnston SL; Singanayagam A; Hanna GB
Am J Respir Crit Care Med; 2021 Nov; 204(9):1075-1085. PubMed ID: 34319857
[No Abstract] [Full Text] [Related]
35. Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis.
Nyilas S; Schreder T; Singer F; Poellinger A; Geiser TK; Latzin P; Funke M
Respirology; 2018 Aug; 23(8):764-770. PubMed ID: 29573509
[TBL] [Abstract][Full Text] [Related]
36. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
[TBL] [Abstract][Full Text] [Related]
37. Sensors for detecting pulmonary diseases from exhaled breath.
Hashoul D; Haick H
Eur Respir Rev; 2019 Jun; 28(152):. PubMed ID: 31243097
[TBL] [Abstract][Full Text] [Related]
38. Body composition, muscle function, and physical performance in fibrotic interstitial lung disease: a prospective cohort study.
Guler SA; Hur SA; Lear SA; Camp PG; Ryerson CJ
Respir Res; 2019 Mar; 20(1):56. PubMed ID: 30866948
[TBL] [Abstract][Full Text] [Related]
39. Imaging biomarkers of lung ventilation in interstitial lung disease from
Tibiletti M; Eaden JA; Naish JH; Hughes PJC; Waterton JC; Heaton MJ; Chaudhuri N; Skeoch S; Bruce IN; Bianchi S; Wild JM; Parker GJM
Magn Reson Imaging; 2023 Jan; 95():39-49. PubMed ID: 36252693
[TBL] [Abstract][Full Text] [Related]
40. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
